DUPHAPEN & STREP SUSPENSION FOR INJECTION

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

PROCAINE PENICILLIN G, DIHYDROSTREPTOMYCIN SULFATE

Available from:

Zoetis Ireland Limited

ATC code:

QJ01RA01

INN (International Name):

PROCAINE PENICILLIN G, DIHYDROSTREPTOMYCIN SULFATE

Dosage:

200/200 Mg/Ml

Pharmaceutical form:

Suspension for Injection

Prescription type:

POM

Therapeutic group:

Bovine, Ovine, Porcine

Therapeutic area:

Penicillins, combinations with other antibacterials

Therapeutic indications:

Antibacterial

Authorization status:

Authorised

Authorization date:

2013-08-23

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Duphapen & Strep Suspension for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Suspension for injection.
A white to off-white suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, Sheep, Pigs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of systemic infections caused by or associated with organisms sensitive to penicillin and/or
streptomycin including:
_Corynebacterium pyogenes_
_Erysipelothrix rhusiopathiae_
_Klebsiella pneumoniae_
_Listeria spp_
_Pasteurella haemolytica_
_Pasteurella multocida_
_Staphylococcus spp. (_non penicillinase producing)
_Streptococcus spp._
Duphapen & Strep will therefore be effective in the treatment of infections caused by susceptible organisms including:
erysipelas; navel/joint ill; respiratory tract infections, including pneumonia and atrophic rhinitis; listeriosis, meningitis;
septicaemia; toxaemia associated with mastitis; urogenital tract infections; enteritis and the control of secondary
bacterial invaders in diseases of primary viral origin.
Each ml contains:
Active Susbtance:
Procaine Benzylpenicillin
200
mg
Dihydrostreptomycin Sulphate
(equivalent to Dihydrostreptomycin)
200
mg
Excipients:
Hydroxybenzoate esters (as preservative)
1.5 mg
Sodium Formaldehyde Sulfoxylate (as antioxidant)
1.25 mg
For a full list of excipients see section 6.1
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 01/04/2014_
_CRN 7017505_
_page number: 1_
4.3 CONTRAINDICATIONS
Not for intravenous administration.
Not for use in sheep producing milk for human consumption.
Contra-indicated in known cases of hypersensitivity to penicillins
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Occasionally in�